on NANOBIOTIX (EPA:NANO)
Nanobiotix Announces Voting Rights and Share Capital Details
On September 12, 2025, Nanobiotix, a biotechnology firm listed on both Euronext Paris and Nasdaq, disclosed its voting rights and share capital details. As of August 31, 2025, the company reported 48,236,771 outstanding shares. The total theoretical voting rights amounted to 50,337,954, while the exercisable voting rights were 50,315,836.
This information follows French financial regulations, ensuring transparency within the market. Nanobiotix, operating since 2003 and a pioneer in physics-based medical treatments, maintains a solid presence in both European and American markets.
The company's philosophy focuses on expanding possibilities for human life, upheld by its significant patent portfolio and technological platforms in oncology and neuroscience.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news